Activation of Serotonin 2C Receptors in Dopamine Neurons Inhibits Binge-like Eating in Mice

Pingwen Xu,Yanlin He,Xuehong Cao,Lourdes Valencia-Torres,Xiaofeng Yan,Kenji Saito,Chunmei Wang,Yongjie Yang,Antentor Hinton,Liangru Zhu,Gang Shu,Martin G. Myers,Qi Wu,Qingchun Tong,Lora K. Heisler,Yong Xu
DOI: https://doi.org/10.1016/j.biopsych.2016.06.005
IF: 12.81
2017-01-01
Biological Psychiatry
Abstract:BACKGROUND: Neural networks that regulate binge eating remain to be identified, and effective treatments for binge eating are limited.METHODS: We combined neuroanatomic, pharmacologic, electrophysiological, Cre-lox, and chemogenetic approaches to investigate the functions of 5-hydroxytryptamine (5-HT) 2C receptor (5-HT2CR) expressed by dopamine (DA) neurons in the regulation of binge-like eating behavior in mice.RESULTS: We showed that 5-HT stimulates DA neural activity through a 5-HT2CR-mediated mechanism, and activation of this midbrain 5-HT -> DA neural circuit effectively inhibits binge-like eating behavior in mice. Notably, 5-HT medications, including fluoxetine, d-fenfluramine, and lorcaserin (a selective 5-HT2CR agonist), act on 5-HT2CRs expressed by DA neurons to inhibit binge-like eating in mice.CONCLUSIONS: We identified the 5-HT2CR population in DA neurons as one potential target for antibinge therapies, and provided preclinical evidence that 5-HT2CR agonists could be used to treat binge eating.
What problem does this paper attempt to address?